TP53 and central nervous system cancer: In addition, inhibition of RPS9 resulted in diminished production of 18S ribosomal RNA and remarkably enhanced p53-dependent morphological differentiation of U343Mga C12:6 glioma cells (Lindström & Nistér, 2010).